Biotech · Private company
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Track this companyFree. Adds Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BomedemstatPhase 2 · Essential ThrombocythemiaClinicalTrials.gov · fetched Nov 12, 2026
- BomedemstatPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- BomedemstatPhase 2 · Polycythemia VeraClinicalTrials.gov · fetched Nov 12, 2026
- BomedemstatPhase 2 · Thrombocythemia, EssentialClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)PHASE2 · COMPLETED · started Sep 7, 2023ClinicalTrials.gov NCT05558696 · fetched Nov 12, 2026
- Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPHASE1 · RECRUITING · started Nov 19, 2022ClinicalTrials.gov NCT05597306 · fetched Nov 12, 2026
- Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung CancerPHASE1_PHASE2 · TERMINATED · started Apr 11, 2022ClinicalTrials.gov NCT05191797 · fetched Nov 12, 2026
- An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)PHASE2 · COMPLETED · started Dec 15, 2021ClinicalTrials.gov NCT05223920 · fetched Nov 12, 2026
- IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 2, 2020ClinicalTrials.gov NCT04262141 · fetched Nov 12, 2026
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)PHASE2 · COMPLETED · started Sep 8, 2020ClinicalTrials.gov NCT04254978 · fetched Nov 12, 2026
- Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 9, 2020ClinicalTrials.gov NCT04081220 · fetched Nov 12, 2026
- Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)PHASE1_PHASE2 · COMPLETED · started Jul 18, 2017ClinicalTrials.gov NCT03136185 · fetched Nov 12, 2026